Debulking surgery in advanced melanoma

References

• Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. Melanoma of the skin. In: Cancer Staging Handbook (Seventh Edition). American Joint Committee on Cancer, Springer-Verlag, New York, NY, USA (2010).
   Google Scholar
• Balch CM, Gershenwald JE, Soong SJ et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol.27(36), 6199–6206 (2009).
   PubMed Web of Science ®Google Scholar
• Meyer T, Merkel S, Goehl J, Hohenberger W. Surgical therapy for distant metastases of malignant melanoma. Cancer89(9), 1983–1991 (2000).
   PubMed Web of Science ®Google Scholar
• Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced stage melanoma. Arch. Surg.139, 961–967 (2004).
   PubMedGoogle Scholar
• Hodi FS, O’Day SJ, Mcdermott DK et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med.363(8), 711–723 (2010).
   PubMed Web of Science ®Google Scholar
• McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann. Surg. Oncol.8(1), 38–43 (2001).
   Google Scholar
• Pulitano C, Bodingbauer M, Aldrighetti L et al. Liver resection for colorectal metastases in presence of extrahepatic disease: Results form an international multi-institutional analysis. Ann. Surg. Oncol.18(5), 1380–1388 (2010).
   Google Scholar
• Sugarbaker P. Peritonectomy procedures. Ann. Surg.221(1), 29–42 (1995).
   PubMed Web of Science ®Google Scholar
• Guarneri V, Piacentini F, Barbieri E, Conte PF. Achievements and unmet needs in the management of advanced ovarian cancer. Gynecol. Oncol.117, 152–158 (2010).
   PubMed Web of Science ®Google Scholar
• Chi DS, Barakat RR, Surgical management of advanced or recurrent endometrial cancer. Surg Clin North Am.81(4), 885–896 (2001).
   Google Scholar
• Esquivel J, Sticca R, Sugarbaker P et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann. Surg. Oncol.14(1), 128–133 (2006).
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin. Surg. Oncol.14, 254–261 (1998).
   PubMedGoogle Scholar
• McLoughlin JM, Zager JS, Sondak VK. Cytoreductive surgery for melanoma. Surg. Oncol. Clin. N. Am.16, 683–693 (2007).
   Google Scholar
• McLoughlin JM, Zager JS, Sondak VK, Berk LB. Treatment options for limited or symptomatic metastatic melanoma. Cancer Control.15(3), 239–247 (2008).
   Google Scholar
• Sondak VK, Liu PY, Warneke J et al. Surgical resection for stage 4 melanoma: a Southwest Oncology Group Trial (S9430). J. Clin. Oncol. ASCO Ann. Meeting Proc.24(18S), 8019 (2006).
   Google Scholar
• Sosman JA, Moon J, Tuthill RJ et al. A Phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430. Cancer DOI: 10.1002/cncr.26111 (2011) (Epub ahead of print).
   Google Scholar
• Herman P, Machado MAC, Montagnini AL et al. Selected patients with metastatic melanoma may benefit from liver resection. World J. Surg.31, 171–174 (2007).
   Google Scholar
• Pawlik TM, Zorzi D, Abdalla EK et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann. Surg. Oncol.13(5), 712–720 (2006).
   PubMed Web of Science ®Google Scholar
• Rose MD, Essner R, Hughes MD et al. Surgical resection for metastatic melanoma to the liver. Arch. Surg.136, 950–955 (2001).
   PubMedGoogle Scholar
• Agrawal S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann. Surg. Oncol.6(4), 336–344 (1999).
   PubMedGoogle Scholar
• Ollila DW, Essner R, Wanek LA, Morton DL. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch. Surg.131, 975–978 (1996).
   PubMedGoogle Scholar
• Petersen RP, Hanish SI, Haney JC et al. Improved survival with pulmonary metastatectomy: an analysis of the 1720 patients with pulmonary metastatic melanoma. J. Thorac. Cardiovasc. Surg.133, 104–110 (2007).
   PubMed Web of Science ®Google Scholar
• Harpole DH, Johnson CM, Wolfe WG, George SL, Seigler HF. Analysis of 945 cases of pulmonary metastatic melanoma. J. Thorac. Cardiovasc. Surg.103(4), 743–748 (1992).
   PubMed Web of Science ®Google Scholar
• Gorenstein LA, Putnam JB, Natarajan G, Balch CA, Roth JA. Improved survival after resection of pulmonary metastases form malignant melanoma. Ann. Thorac. Surg.52, 204–210 (1991).
   PubMed Web of Science ®Google Scholar
• Meier S, Baumer BG, Maier T et al. survival and prognostic factors in patients with brain metastases form malignant melanoma. Onkologie27, 145–149 (2004).
   PubMedGoogle Scholar
• Fife KM, Colman MH, Stevens GN et al. Determinants of outcome in melanoma patients with cerebral metastases. J. Clin. Oncol.22(7), 1293–1300 (2004).
   PubMed Web of Science ®Google Scholar
• Selek U, Chang EL, Hassenbusch SJ. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int. J. Radiation Oncology. Biol. Phys.59(4), 1097–1106 (2004).
   PubMed Web of Science ®Google Scholar
• De Wilt J, McCrthy WH Thompson JF. Surgical treatment of splenic metastases in patients with melanoma. J. Am. Coll. Surg.197(1), 38–43 (2003).
   PubMed Web of Science ®Google Scholar
• Wornom IL, Soong SJ, Urist MM et al. Surgery as palliative treatment for distant metastases of melanoma. Ann. Surg.204(2), 181–185 (1986).
   PubMedGoogle Scholar
• Coleman A, Augustine CK, Beasley G, Sanders G, Tyler D. Optimizing regional infusion treatment strategies for melanoma of the extremities. Expert Rev. Anticancer. Ther.9(11), 1599–1609 (2009).
   PubMed Web of Science ®Google Scholar
• Kroon HM, Thompson JF. Isolated limb infusion; a review. J. Surg. Oncol.100, 169–177 (2009).
   PubMed Web of Science ®Google Scholar
• Beasley GM, Caudle A, Petersen RP et al. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg208, 706–717 (2009).
   PubMed Web of Science ®Google Scholar
• Flaherty KT, Puzanov I, Kim KB, Ribas A et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N. Engl. J. Med.363(9), 809–819 (2010).
   PubMed Web of Science ®Google Scholar
• Johannessen CM, Boehm JS, Kim SY et al. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature468(7326), 968–972 (2010).
   PubMed Web of Science ®Google Scholar
• DeMatteo RP, Ballman KV, Antonescu CR et al. Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumour: a randomized, double-blind, placebo-controlled trial. Lancet373, 1097–1104 (2009).
   PubMed Web of Science ®Google Scholar
• Winer JH, Raut CP. Management of recurrent gastrointestinal stromal tumors. J. Surg. Oncol. DOI: 10.1002/jso.21890 (2011) (Epub ahead of print).
   Google Scholar
• Raut CP, Wang Q, Manola J et al. Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitib malate. Ann. Surg. Oncol.17, 407–415 (2010).
   PubMed Web of Science ®Google Scholar
• Ollila DW, Hsueh EC, Stern SL, Morton DL. Metastatectomy for recurrent stage IV disease. J. Surg. Oncol.71, 209–213 (1999).
   PubMed Web of Science ®Google Scholar